Financhill
Back

EyePoint Pharmaceuticals Vs. Adverum Biotechnologies Industry Stock Comparison

Sell
40

EYPT
EyePoint Pharmaceuticals

Last Price:
8.21
Seasonality Move:
-9.25%
Sell
32

ADVM
Adverum Biotechnologies

Last Price:
6.82
Seasonality Move:
-1.86%
Sell
40
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $8.01. The Score for EYPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Adverum Biotechnologies (ADVM) is a Sell

Is Adverum Biotechnologies a Buy, Sell or Hold?

  • The current Adverum Biotechnologies [ADVM] share price is $6.59. The Score for ADVM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ADVM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $8.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADVM Stock Price Chart

What is Adverum Biotechnologies's stock price today?

  • The Adverum Biotechnologies share price today is $6.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADVM is experiencing selling pressure, which indicates risk of future bearish movement.

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 42.06 Sell
Chaikin Money Flow: 232993 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.06 - 8.9) Sell
Bollinger Bands (100): (8.03 - 10.53) Sell

ADVM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 42.65 Sell
Chaikin Money Flow: -165680 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.74 - 7.22) Sell
Bollinger Bands (100): (6.72 - 8.12) Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.22 Sell
20-day SMA: 8.42 Sell
50-day SMA: 8.66 Sell
200-day SMA: 15.98 Sell
8-day EMA: 8.2 Sell
20-day EMA: 8.4 Sell
50-day EMA: 8.83 Sell
200-day EMA: 12.03 Sell

ADVM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.88 Sell
20-day SMA: 6.99 Sell
50-day SMA: 7.07 Sell
200-day SMA: 10.35 Sell
8-day EMA: 6.86 Sell
20-day EMA: 6.96 Sell
50-day EMA: 7.19 Sell
200-day EMA: 9.37 Sell

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.94 per share.

Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.62 per share, and an increase next year of $0.42 per share.

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adverum Biotechnologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):